TLDR Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.
The document discussed drug repositioning as an alternative to traditional drug discovery, highlighting its cost-effectiveness and reduced risk due to pre-existing safety and efficacy data. This approach was particularly beneficial for treating rare, orphan, and resistant diseases, as well as urgent pandemic outbreaks like COVID-19. Drugs such as Hydroxychloroquine, Remdesivir, Ivermectin, and Baricitinib were identified as having potential for COVID-19 treatment. The review covered past successes, technological advancements, and ongoing research in drug repositioning, emphasizing its role in personalized medicine and addressing urgent health crises.
73 citations
,
September 2016 in “Journal of Translational Medicine” Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.
81 citations
,
March 2009 in “Seminars in Cutaneous Medicine and Surgery” Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.
212 citations
,
September 2008 in “Journal of The American Academy of Dermatology” Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.
397 citations
,
February 2004 in “British Journal of Dermatology” Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.
March 1988 in “Archives of Dermatology” Minoxidil therapy can help with hair regrowth, but results vary and some people are just happy to stop further hair loss.
4 citations
,
March 1988 in “PubMed” 
86 citations
,
September 1977 in “BMJ” Minoxidil effectively controls blood pressure in severe cases, but has serious side effects and causes hair growth in women.
